HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$8.09
Day range
$8.10 - $8.66
Year range
$2.55 - $11.27
Market cap
805.79M USD
Avg Volume
805.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 6.82M | -36.44% |
Net income | -7.17M | 50.32% |
Net profit margin | — | — |
Earnings per share | -0.07 | 22.22% |
EBITDA | -10.21M | 28.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 228.36M | -16.77% |
Total assets | 233.19M | -17.14% |
Total liabilities | 2.43M | -71.60% |
Total equity | 230.76M | — |
Shares outstanding | 96.50M | — |
Price to book | 3.38 | — |
Return on assets | -10.61% | — |
Return on capital | -10.91% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.17M | 50.32% |
Cash from operations | -17.40M | 15.09% |
Cash from investing | 26.04M | 20,765.87% |
Cash from financing | 1.80M | -99.07% |
Net change in cash | 10.44M | -93.97% |
Free cash flow | -13.60M | -158.97% |
About
Founded
2015
Website
Employees
25